Address requests for reprints to: Society of Critical Care Medicine, One East Erie Street, Suite 200, Chicago, IL 60610; or American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111.
This Position Paper has been developed by a Task Force of the Clinical Pharmacy and Pharmacology Section of the Society of Critical Care Medicine and the American College of Clinical Pharmacy. It was reviewed and approved by the Council of the Society of Critical Care Medicine and the Board of Regents of the American College of Clinical Pharmacy.
The Task Force members were Maria I. Rudis, PharmD, ABAT, BCPS, University of Southern California (Chair); Katherine M. Brandl, PharmD, BCPS, University of New Mexico, Albuquerque, NM (co-author); Henry Cohen, PharmD, Long Island University, NY, NY; Bradley E. Cooper, PharmD, Hamot Medical Center, Erie, PA; Luis S. Gonzalez III, PharmD, BCPS, Conemaugh Medical Center, Erie, PA; Erkan Hassan, PharmD, FCCM, IC-USA, Baltimore, MD; Christian Klem, PharmD, BCPS, Bristol Myers Squibb, Tampa, FL; Vanessa L. Kluth-Land, PharmD, Smith-Kline Beecham Pharmaceuticals, Houston, TX; Katherine M. Kramer, PharmD, BCPS, University of New Mexico, Las Cruces, NM; Angela M. Swerlein, PharmD, Grant/Riverside Methodist Hospitals, Columbus, OH, Julie Ann Whipple, PharmD, Waukesha Memorial Hospital, Waukesha WI. At the time of this writing, Dr. Hassan was Associate Professor at the University of Maryland School of Pharmacy, Baltimore, MD; Dr. Christian Klem was at Tampa General Healthcare, Tampa, FL; and Dr. Kluth-Land was at Hermann Hospital; Houston, TX.
Copyright © 2000 by the Society of Critical Care Medicine
